G
Greta Mino
Researcher at Boston Children's Hospital
Publications - 10
Citations - 1154
Greta Mino is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: Meningitis & Medicine. The author has an hindex of 8, co-authored 9 publications receiving 673 citations.
Papers
More filters
Journal ArticleDOI
A living WHO guideline on drugs for covid-19
Bram Rochwerg,Arnav Agarwal,Reed A C Siemieniuk,Thomas Agoritsas,Francois Lamontagne,Lisa Askie,Lyubov Lytvyn,Yee Sin Leo,Helen Macdonald,Linan Zeng,Wagdy Amin,Erlina Burhan,Frédérique Jacquerioz Bausch,Carolyn S. Calfee,Maurizio Cecconi,Duncan Chanda,Bin Du,Heike Geduld,Patrick Gee,Nerina Harley,Madiha Hashimi,Beverly Hunt,Sushil K. Kabra,Seema Kanda,Leticia Kawano-Dourado,Yae-Jean Kim,Niranjan Kissoon,Arthur Kwizera,Imelda Mahaka,Hela Manai,Greta Mino,Emmanuel Nsutebu,Jacobus Preller,Natalia Pshenichnaya,Nida Qadir,Saniya Sabzwari,Rohit Sarin,Manu Shankar-Hari,Mike Sharland,Yinzhong Shen,Shalini Sri Ranganathan,João Paulo Souza,Miriam Stegemann,An De Sutter,Sebastian Ugarte,Sridhar Venkatapuram,Vu Quoc Dat,Dubula Vuyiseka,Ananda Wijewickrama,Brittany J. Maguire,Dena Zeraatkar,Jessica J Bartoszko,Long Ge,Long Ge,Romina Brignardello-Petersen,Andrew Owen,Gordon H. Guyatt,Janet V. Diaz,Michael Jacobs,Per Olav Vandvik +59 more
TL;DR: A standing international panel of content experts, patients, clinicians, and methodologists, free from relevant conflicts of interest, produce recommendations for clinical practice, containing a strong recommendation for systemic corticosteroids in patients with severe and critical covid-19, and a weak or conditional recommendation against systemic cortiosteroids for non-severe patients.
Journal ArticleDOI
Adjuvant Glycerol and/or Dexamethasone to Improve the Outcomes of Childhood Bacterial Meningitis: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial
Heikki Peltola,Irmeli Roine,Josefina Fernández,Inés Zavala,Silvia González Ayala,Antonio González Mata,Antonio Arbo,Rosa Bologna,Greta Mino,José Goyo,Eduardo López,Solange Dourado de Andrade,Seppo Sarna +12 more
TL;DR: Oral glycerol therapy prevents severe neurological sequelae in patients with childhood meningitis and adds to its usefulness, especially in resource-limited settings.
Journal ArticleDOI
Chloramphenicol versus ampicillin plus gentamicin for community acquired very severe pneumonia among children aged 2-59 months in low resource settings: multicentre randomised controlled trial (SPEAR study).
Rai Asghar,Salem Banajeh,Josefina Egas,Patricia L. Hibberd,Imran Iqbal,Mary Katep-Bwalya,Zafarullah Kundi,Paul A. Law,William B. MacLeod,Irene Maulen-Radovan,Greta Mino,Samir K. Saha,Fernando Sempértegui,Jonathon L Simon,Mathuram Santosham,Sunit Singhi,Donald M. Thea,Shamim Qazi +17 more
TL;DR: Injectable ampicillin plus gentamicin is superior to injectable chloramphenicol for the treatment of community acquired very severe pneumonia in children aged 2-59 months in low resource settings.
Journal ArticleDOI
Influence of Admission Findings on Death and Neurological Outcome from Childhood Bacterial Meningitis
Irmeli Roine,Heikki Peltola,Josefina Fernández,Inés Zavala,Antonio González Mata,Silvia González Ayala,Antonio Arbo,Rosa Bologna,Greta Mino,José Goyo,Eduardo López,Solange Dourado de Andrade,Seppo Sarna +12 more
TL;DR: A post hoc analysis of 654 children with bacterial meningitis showed that the level of consciousness is the most important predictor of death and/or neurological sequelae, more than is etiology per se.
Journal ArticleDOI
Hearing Impairment in Childhood Bacterial Meningitis Is Little Relieved by Dexamethasone or Glycerol
Heikki Peltola,Irmeli Roine,Josefina Fernández,Antonio González Mata,Inés Zavala,Silvia González Ayala,Antonio Arbo,Rosa Bologna,José Goyo,Eduardo López,Greta Mino,Solange Dourado de Andrade,Seppo Sarna,Tapani Jauhiainen +13 more
TL;DR: With bacterial meningitis, the child's presenting status and young age are the most important predictors of hearing impairment, and little relief is obtained from current adjuvant medications.